Article Details

Merck ends development of Covid drug it acquired from OncoImmune

Retrieved on: 2021-04-15 11:18:44

Tags for this article:

Click the tags to see associated articles and topics

Merck ends development of Covid drug it acquired from OncoImmune. View article details on hiswai:

Excerpt

Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo